5-fluorodopamine has been researched along with Cancer of Pancreas in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gesuwan, K; Herscovitch, P; Hughes, MS; Kebebew, E; Kitano, M; Libutti, SK; Linehan, WM; Millo, C; Nilubol, N; Phan, GQ; Rahbari, R; Venkatesan, AM; Webb, RC | 1 |
1 trial(s) available for 5-fluorodopamine and Cancer of Pancreas
Article | Year |
---|---|
Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease.
Topics: Adolescent; Adult; Aged; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; von Hippel-Lindau Disease; Young Adult | 2011 |